Epidemiology and treatment of psoriasis: a Chinese perspective

References

• Ahlehoff O. Psoriasis and cardiovascular disease. Dan Med Bull. 2011;58(11):B4347.
   Google Scholar
• Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol. 2009;145(4):379–382.
   PubMedGoogle Scholar
• Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146(8):891–895.
   PubMed Web of Science ®Google Scholar
• Miller IM, Ellervik C, Yazdanyar S, Jemec GB. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol. 2013;69(6):1014–1024.
   PubMed Web of Science ®Google Scholar
• Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41(3 Pt 1):401–407.
   PubMed Web of Science ®Google Scholar
• Raychaudhuri SP, Farber EM. The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol. 2001;15(1):16–17.
   PubMed Web of Science ®Google Scholar
• Farber EM, Nail L. Epidemiology: natural history and genetics. In: Roenigk HR Jr, Maibach HI, editors. Psoriasis. 3rd ed. Marcel Dekker, New York: 1998:107–157.
   Google Scholar
• Qian XC. Prevalence of psoriasis in Xinjiang region. J Xinjiang Med Univ. 1978;2:204. Chinese.
   Google Scholar
• Psoriasis epidemiology study group. Report on epidemiological survey of psoriasis in China in 1984. J Dermatol Venereol. 1989;11(1):60–72. Chinese.
   Google Scholar
• Xu YY, Tong ZC, Shen SF, et al. An epidemiological investigation on psoriasis in country dwellers of Suzhou area in Anhui Province. Acta Anhui Med Univ. 2001;36(6):483–485. Chinese.
   Google Scholar
• Ding X, Wang T, Shen Y, et al. Prevalence of psoriasis in China: a population-based study in six cities. Eur J Dermatol. 2012;22(5):663–667.
   PubMed Web of Science ®Google Scholar
• Li MJ, Wang P, Cai M, et al. Prevalence and risk factors of psoriasis in Hainan province: an epidemiological survey. Chin J Dermatol. 2013;46(3):157–159. Chinese.
   Google Scholar
• Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13(3):450–456.
   PubMed Web of Science ®Google Scholar
• Fry L. Psoriasis. Br J Dermatol. 1988;119(4):445–461.
   Web of Science ®Google Scholar
• Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009;60(3):394–401.
   PubMed Web of Science ®Google Scholar
• Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol. 2010;76(6):595–601.
   PubMed Web of Science ®Google Scholar
• Wei J, Liu M, Qu L, Xiao T, Cheng HD, He CD. Clinical and epidemiological study of 531 patients with psoriasis vulgaris in Liaoning region. Int J Dermatol Venereol. 2011;37(1):4–6. Chinese.
   Google Scholar
• Kawada A, Tezuka T, Nakamizo Y, et al. A survey of psoriasis patients in Japan from 1982 to 2001. J Dermatol Sci. 2003;31(1):59–64.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Takahashi I, Tsuji H, et al. Analysis of psoriatic patients registered in Asahikawa Medical College Hospital from 1983 to 2007. J Dematol. 2009;36(12):632–637.
   Google Scholar
• Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729–735.
   PubMed Web of Science ®Google Scholar
• Baek HJ, Yoo CD, Shin KC, et al. Spondylitis is the most common pattern of psoriatic arthritis in Korea. Rheumatol Int. 2000;19(3):89–94.
   Web of Science ®Google Scholar
• Jamshidi F, Bouzari N, Seirafi H, Farnaghi F, Firooz A. The prevalence of psoriatic arthritis in psoriatic patients in Tehran, Iran. Arch Iran Med. 2008;11(2):162–165.
   PubMed Web of Science ®Google Scholar
• Kundakci N, Tursen U, Babiker MO, Gurgey E. The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients. Int J Dermatol. 2002;41(4):220–224.
   Web of Science ®Google Scholar
• Grjibovski AM, Olsen AO, Magnus P, Harris JR. Psoriasis in Norwegian twins: contribution of genetic and environmental effects. J Eur Acad Dermatol Venereol. 2007;21(10):1337–1343.
   Web of Science ®Google Scholar
• Jesic S, Hosovski E. Prevalence of psoriasis vulgaris in West Serbia. Srp Arh Celok Lek. 1994;122(3–4):61–64.
   Google Scholar
• Zhang XJ, Chen SY, Wang FX, et al. Analyses of genetic epidemiology of psoriasis vulgaris. Chin J Dermatol. 2000;33(6):383–385. Chinese.
   Google Scholar
• Jiang YM. Analysis of the induct factor inquisition result of 364 cases psoriasis. J Clin Exp Med. 2006;5(3):215–216. Chinese.
   Google Scholar
• Tan Pei Lin L, Kwek SK. Onset of psoriasis during therapy with fluoxetine. Gen Hosp Psychiatry. 2010;32(4):466.
   Google Scholar
• Song R. A case of ampicillin induced psoriasis. Chin J Derm Venereol. 1996;10(1):59. Chinese.
   Google Scholar
• Zhang GH. Analysis of 11 cases of chlorpromazine induced psoriasis. Sichuan Mental Health. 1997;10(4):275. Chinese.
   Google Scholar
• Zhu CX, Ling YL. A case of procaine induced psoriasis. Chin J Derm Venereol. 1997;11(5):315. Chinese.
   Google Scholar
• Zhu BY. A case of rabies vaccine induced psoriasis. Chin J Derm Venereol. 1999;13(2):116. Chinese.
   Google Scholar
• Tian L, Huang ML, Gao Y. A case of hepatitis B vaccine induced psoriasis of newborn. J Dermatol Venereol. 2000;22(3):41–42. Chinese.
   Google Scholar
• Kim GK, Del Rosso JQ. Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance. J Clin Aesthet Dermatol. 2010;3(1):32–38.
   PubMedGoogle Scholar
• Dika E, Varotti C, Bardazzi F, Maibach HI. Drug-induced psoriasis: an evidence-based overview and the introduction of psoriatic drug eruption probability score. Cutan Ocul Toxicol. 2006;25(1):1–11.
   PubMed Web of Science ®Google Scholar
• Cohen AD, Bonneh DY, Reuveni H, Vardy DA, Naggan L, Halevy S. Drug exposure and psoriasis vulgaris: case-control and case-crossover studies. Acta Derm Venereol. 2005;85(4):299–303.
   PubMed Web of Science ®Google Scholar
• Cohen AD, Kagen M, Friger M, Halevy S. Calcium channel blockers intake and psoriasis: a case-control study. Acta Derm Venereol. 2001; 81(5):347–349.
   PubMed Web of Science ®Google Scholar
• Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin Dermatol. 2007;25(6):606–615.
   PubMed Web of Science ®Google Scholar
• Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses’ Health Study. Arch Intern Med. 2007;167(15):1670–1675.
   PubMed Web of Science ®Google Scholar
• Bryld LE, Sorensen TI, Andersen KK, Jemec GB, Baker JL. High body mass index in adolescent girls precedes psoriasis hospitalization. Acta Derm Venereol. 2010;90(5):488–493.
   Web of Science ®Google Scholar
• Zhang C, Zhu KJ, Zheng HF, et al. The effect of overweight and obesity on psoriasis patients in Chinese Han population: a hospital-based study. J Eur Acad Dermatol Venereol. 2011;25(1):87–91.
   Web of Science ®Google Scholar
• Cheng J, Yang XQ, Zhang L, Feng YJ, Liu F, Hui RS. Clinical features of 114 psoriasis vulgaris patients with abnormal body mass index. Medical Journal of Chinese People’s Liberation Army. 2009;34(3):252–253, 258. Chinese.
   Google Scholar
• Naldi L, Addis A, Chimenti S, et al. Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project. Dermatology. 2008;217(4):365–373.
   PubMed Web of Science ®Google Scholar
• Di Lernia V, Tasin L, Pellicano R, Zumiani G, Albertini G. Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis. J Dermatolog Treat. 2012;23(6):404–409.
   PubMed Web of Science ®Google Scholar
• Gisondi P, Del Giglio M, Di Francesco V, Zamboni M, Girolomoni G. Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr. 2008;88(5):1242–1247.
   PubMed Web of Science ®Google Scholar
• Setty AR, Curhan G, Choi HK. Smoking and the risk of psoriasis in women: Nurses’ Health Study II. Am J Med. 2007;120(11):953–959.
   Web of Science ®Google Scholar
• Li W, Han J, Choi HK, Qureshi AA. Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis. Am J Epidemiol. 2012;175(5):402–413.
   PubMed Web of Science ®Google Scholar
• Zhang XJ, Wang FX, Yang S, et al. Analysis of the relationship between smoking, alcoholism and psoriasis. Chin J Derm Venereol. 2000;14(4):221–222. Chinese.
   Google Scholar
• Verhoeven EW, Kraaimaat FW, Jong EM, Schalkwijk J, van de Kerkhof PC, Evers AW. Effect of daily stressors on psoriasis: a prospective study. J Invest Dermatol. 2009;129(8):2075–2077.
   Web of Science ®Google Scholar
• Fortune DG, Richards HL, Kirby B, et al. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol. 2003;139(6):752–756.
   PubMedGoogle Scholar
• Zhang GW, Shao CG, Wang GC. The annual incidence and susceptible rate of age in China. J Dermatol Venereol. 1990;(1):62–68. Chinese.
   Google Scholar
• Jacobson CC, Kumar S, Kimball AB. Latitude and psoriasis prevalence. J Am Acad Dermatol. 2011;65(4):870–873.
   Web of Science ®Google Scholar
• Lee H, Lee IS, Choue R. Obesity, inflammation and diet. Pediatr Gastroenterol Hepatol Nutr. 2013;16(3):143–152.
   PubMedGoogle Scholar
• Wei SP, Si RL, Zhang XG, et al. Logistic regression analysis on risk factors of psoriasis. Chin J Dermatol. 2004;37(11):665–666. Chinese.
   Google Scholar
• Tong ZC, Xu YY, Shen SF, et al. Logistic regression analysis on risk factors of psoriasis. Chin J Dis Control Prev. 2002;6(4):319–320. Chinese.
   Google Scholar
• Telfer NR, Chalmers RJ, Whale K, Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol. 1992;128(1):39–42.
   PubMedGoogle Scholar
• Wu W, Debbaneh M, Moslehi H, Koo J, Liao W. Tonsillectomy as a treatment for psoriasis: a review. J Dermatolog Treat. 2014;25(6):482–486.
   PubMed Web of Science ®Google Scholar
• Huerta C, Rivero E, Rodriguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol. 2007;143(12):1559–1565.
   PubMedGoogle Scholar
• Wu Y, Lin Y, Liu HJ, Huang CZ, Feng AP, Li JW. Childhood psoriasis: a study of 137 cases from central China. World J Pediatr. 2010;6(3):260–264.
   PubMed Web of Science ®Google Scholar
• Chiam LY, de Jager ME, Giam YC, de Jong EM, van de Kerkhof PC, Seyger MM. Juvenile psoriasis in European and Asian children: similarities and differences. Br J Dermatol. 2011;164(5):1101–1103.
   PubMed Web of Science ®Google Scholar
• Psoriasis working group of Chinese society of Dermatology. Guidelines for management of psoriasis 2008. Chin J Dermatol. 2009;42(3):213–214. Chinese.
   Google Scholar
• Hu JW. Clinical observation of tacalcitol combined with emollient in the treatment of psoriasis vulgaris. Chinese Manipulation and Rehabilitation Medicine. 2011;2(1):11–12. Chinese.
   Google Scholar
• Qi L, Liu LF. 30 cases of psoriasis vulgaris treated with emollient. Henan Traditional Chinese Medicine. 2010;30(11):1099–1100. Chinese.
   Google Scholar
• Wang HB, He L, Chen SH. Narrow band UVB combined with emollient in the treatment of psoriasis vulgaris. J Dermatol Venereol. 2013;35(1):29–30. Chinese.
   Google Scholar
• Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005;141(12):1537–1541.
   PubMedGoogle Scholar
• Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60(4):643–659.
   PubMed Web of Science ®Google Scholar
• Peng ZH, Pan M, Ren JW. Comparison of the efficacy and safety of 0.05% desonide cream in patients with three common dermatoses. Chin J Derm Venereol. 2009;23(1):63–64. Chinese.
   Google Scholar
• Ji SZ, Yang HZ, Li LF, et al. Treatment of plaque psoriasis with momerasonefuroate: a multicenter, open-label trial. J ClinDermatol. 2004;33(4):242–243. Chinese.
   Google Scholar
• Huang L, Ma L, Huang Q, et al. Calcipotriol betamethasone ointment in the treatment of psoriasis vulgaris: a randomized, double-blind, active-control, parallel group study. Chin J Dermatol. 2009;42(10):691–694. Chinese.
   Google Scholar
• du Vivier A, Stoughton RB. Tachyphylaxis to action of topically applied corticosteroid. Arch Dermatol. 1975;111(5):581–583.
   Google Scholar
• Miller JJ, Roling D, Margolis D, Guzzo C. Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasis. J Am Acad Dermatol. 1999;41(4):546–549.
   PubMed Web of Science ®Google Scholar
• Feldman SR. Tachyphylaxis to topical corticosteroids: the more you use them, the less they work? Clin Dermatol. 2006;24(3):229–230.
   Web of Science ®Google Scholar
• Ji SZ, Chen XX, Wang BX, et al. Calcitriol ointment versus calcipotriol ointment in the treatment of psoriasis: a single-blind, randomized, multicenter trial. Chin J Dermatol. 2008;41(3):153–156. Chinese.
   Google Scholar
• Zhang J, Diao QC, Yan GF, Zhu XJ. Observation of efficacy and safety of tazarotene ointment in the treatment of plaque psoriasis. Chong Qing Yi Xue. 2008;37(12):1293–1294. Chinese.
   Google Scholar
• Li H, Li GM, Zhou X, et al. The efficacy of tazarotene and calcipotriol in the treatment of plaque psoriasis. Chin J New Drugs Clin Rem. 2002;21(3):155–158. Chinese.
   Google Scholar
• He YL, Guo ZP. Clinical efficacy of 0.1% tarcrolimus ointment on plaque psoriasis of scalp and face. J Clin Dermatol. 2008;37(4):254–255. Chinese.
   Google Scholar
• Zhao N, Jin HZ. Efficacy and safety of tacrolimus ointment and calcipotriol ointment in the treatment of plaque psoriasis. J Clin Dermatol. 2012;41(10):626–628. Chinese.
   Google Scholar
• Zhong CM, Sun LD, Zeng H, Zhou ZG, He FJ. A clinical trial of 0.1% tacrolimus in the treatment of psoriasis vulgaris. J Clin Dermatol. 2010;39(8):531–532. Chinese.
   Google Scholar
• Li W, Wang LX, Liu Y, Zhang XB. Clinical efficacy of 0.03% topical tacrolimus ointment combined with 308 nm excimer laser in treatment of psoriasis vulgaris. Chin J Derm Venereol. 2012;26(12):1152–1154. Chinese.
   Google Scholar
• Zhang TZ, Zhou FH, Huang XR, Zhang Q, Liu XL, Zhou XY. Analysis of clinical efficacy of PUVA and narrow band ultraviolet B in the treatment of psoriasis vulgaris. J Clin Dermatol. 2006;35(2):111–112. Chinese.
   Google Scholar
• Gordon PM, Diffey BL, Matthews JN, Farr PM. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol. 1999;41(5 Pt 1):728–732.
   Web of Science ®Google Scholar
• Yones SS, Palmer RA, Garibaldinos TT, Hawk JL. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy. Arch Dermatol. 2006;142(7):836–842.
   PubMedGoogle Scholar
• Li JY, Guo ZP. Analysis of clinical efficacy of 311 nm narrow band UVB and 280–320 nm broad band UVB phototherapy in chronic plaque psoriasis. J Clin Dermatol. 2006;35(3):185–187. Chinese.
   Google Scholar
• Cameron H, Dawe RS, Yule S, Murphy J, Ibbotson SH, Ferguson J. A randomized, observer-blinded trial of twice vs three times weekly narrow-band ultraviolet B phototherapy for chronic plaque psoriasis. Br J Dermatol. 2002;147(5):973–978.
   Web of Science ®Google Scholar
• Li YT, Shi TX, Qin ZF. Clinical study on the treatment of psoriasis with narrow-band UVB. J Clin Dermatol. 2012;41(12):763–764. Chinese.
   Google Scholar
• Liu ZR, Gao TW, Li TH, et al. Observation of the efficacy of 311 nm narrow-band ultraviolet B phototherapy in psoriasis vulgaris. J Clin Dermatol. 2004;33(6):373–375. Chinese.
   Google Scholar
• Wang DY, Peng ZH, Ge WY, Liu P, Wang YX, Tan SS. Observation of the efficacy of narrow-band ultraviolet B phototherapy combined with acitretin on plaque psoriasis. Chin J Derm Venereol. 2005;19(8):477–478. Chinese.
   Google Scholar
• Chen ZX, Ni WQ, Wei F. Efficacy of narrow-band ultraviolet B phototherapy combined with methotrexate on psoriasis vulgaris. J Clin Dermatol. 2007;36(9):596–597. Chinese.
   Google Scholar
• Liu W, Zhao G. Efficacy of erythromycin in the treatment of psoriasis guttata. J Clin Dermatol. 2005;34(8):551. Chinese.
   Google Scholar
• Li CX, Zhang XB, Huang ZM, Liu YM, Wu ZH, Chen QX. Methotrexate in the treatment of patients with moderate to severe psoriasis. J Clin Dermatol. 2006;35(5):327–328. Chinese.
   Google Scholar
• Zhang GL, Huang F, Zhang JL, Li XF, Zhang LY, Hao HQ. A clinical study on leflunomide and methotrexate for skin involvement of psoriatic arthritis. Chin J Rheumatol. 2010;14(4):256–259. Chinese.
   Google Scholar
• Wang S, Ai DF, Li SL, Wang Q, Wang XY. The efficacy of cyclosporine A and methotrexate in treatment of severe psoriasis. Chin J Lepr Skin Dis. 2012;28(8):554–555. Chinese.
   Google Scholar
• Maza A, Montaudie H, Sbidian E, et al. Oral cyclosporine in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. J Eur Acad Dermatol Venereol. 2011;25 Suppl 2:19–27.
   Google Scholar
• Yang XY, Chen ZQ. Evaluation on the effectiveness of acitretin in severe psoriasis. J Clin Dermatol. 2003;32(10):610–611. Chinese.
   Google Scholar
• Wang SF, Song SN, Liu XL, Wang YP. Therapeutic effect of narrow-band UVB in combination with acitretin in treating 150 cases of psoriasis. Chin J Derm Venereol. 2008;22(3):192–193. Chinese.
   Google Scholar
• Sbidian E, Maza A, Montaudie H, et al. Efficacy and safety of oral retinoids in different psoriasis subtypes: a systematic literature review. J Eur Acad Dermatol Venereol. 2011;25 Suppl 2:28–33.
   Google Scholar
• Smith CH, Anstey AV, Barker JN, et al. British association of dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol. 2005;153(3):486–497.
   PubMed Web of Science ®Google Scholar
• Huang Q, Yang QP, Fang X, et al. Treatment of psoriasis vulgaris with a recombinant human tumor necrosis factor receptor: Fc fusion protein: a multicenter, randomized, double blind trial. Chin J Dermatol. 2007;40(11):655–658. Chinese.
   Google Scholar
• He QB, Yin GW, Li HW, Dong HT. The observation of efficacy of entanercept in treatment of 20 cases of generalized pustular psoriasis. J Zhengzhou Univ Med. 2010;45(4):668–670. Chinese.
   Google Scholar
• Leonardi CL, Powers JL, Matheson RT, et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med. 2003;349(21):2014–2022.
   PubMed Web of Science ®Google Scholar